share_log
Breakings ·  Jun 14 15:00
Pfizer Inc - Patients in Magnetismm-3 Demonstrated a Median Overall Survival of 24.6 Months, With Median Progression-Free Survival of 17.2 Months
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment